How to increase testosterone naturally: An evidence guide for men
The levers that work mostly bring a suppressed level back toward normal: lose excess weight, avoid short sleep, drink less. They will not turn a normal man into a superhuman. What helps, what is myth, and when a real deficiency is behind it.
Updated 19 min read44 sources
The short answer
The best-supported natural lever is losing excess weight: in men with obesity, a low-calorie diet raised total testosterone by about 2.9 nmol/L, and weight-loss surgery by about 8.7 nmol/L.[2][27] Short sleep lowered testosterone in a small trial and regular drinking goes with lower levels, so avoiding both makes sense.[1][10] Resistance training did not change resting testosterone in men over 60.[3] Among supplements, zinc has a clear job: it may help if you lack it,[5] while vitamin D and over-the-counter boosters showed no reliable testosterone benefit.[11][26][32] None of this lifts a normal level much higher, and a real deficiency is diagnosed by a doctor from symptoms plus two low morning blood tests.[12]
This content is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your diet, exercise routine, or supplement regimen.
How to increase testosterone naturally: What works, and how much?
You can raise testosterone naturally, but mostly by pulling a suppressed level back toward normal rather than pushing a normal one higher. Losing excess weight has by far the strongest numbers behind it. Sleep and alcohol matter in a less clear-cut way, and resistance training barely registers on the resting level. The table shows what each lever did in the studies, and in whom:
| Lever | Effect on testosterone | Evidence |
|---|---|---|
| Low-calorie diet (men with obesity) | about +2.9 nmol/L total testosterone | Meta-analysis,[27] umbrella review,[2] |
| Weight-loss surgery (men with obesity) | about +8.7 nmol/L total testosterone | Meta-analysis[27] umbrella review,[2] |
| Avoid sleep restriction | under 5 h for a week lowered it 10 to 15 percent in 10 young men; pooled data mixed | Small trial[1] meta-analysis.[28] |
| Cut back regular drinking | regular drinkers had lower total and free testosterone | Meta-analysis[10] |
| Resistance training | no change in resting level (men 60+) | Meta-analysis[3] |
| Endurance or interval training | small rise in resting level (men 60+) | Meta-analysis[3] |
| CPAP for sleep apnea | no change on average | Small meta-analysis[4] |
| Zinc | may help in deficiency; mostly animal data | Systematic review[5] |
| Vitamin D | no clear effect | RCT and meta-analyses[6][7][8][32] |
| D-aspartic acid, Tribulus | no proven rise | Trials and review[11][25][26] |
The two weight rows stand out, and both come from men with obesity. In that group, a low-calorie diet raised total testosterone by about 2.9 nmol/L (about 83 ng/dL) on average[2][27] Weight-loss surgery raised it by about 8.7 nmol/L (about 250 ng/dL).[2][27] The rise was larger in men who lost more weight and in men with more severe obesity.[27]
Those gains undo a suppression that the extra weight had caused. Weight loss lowered estrogen and raised the brain signals that tell the testes to make testosterone.[27] The big number belongs to surgery, not to a five-kilo cut before the summer holidays. So the realistic promise is getting back what excess weight took away. On this evidence we would start with weight, and the men with the most to gain are those carrying a lot of it.
Sleep is the lever people name next, and its evidence is thinner than its reputation. In one small experiment, 10 healthy young men first spent three nights with 10 hours in bed and then eight nights with only 5 hours. On the short nights they slept under 5 hours, and their daytime testosterone was 10 to 15 percent lower than when rested.[1] Pooled studies are less clear, because short-term partial sleep restriction showed no clear effect, while a full night without sleep did lower testosterone.[28] So the goal is to avoid chronic short sleep, since no study here showed that extra sleep raises testosterone in men who already sleep enough.
Alcohol is the other everyday lever, and its evidence comes from comparing regular drinkers with non-drinkers.[10] In a meta-analysis, regular drinkers had lower total testosterone and lower free testosterone, the small share that is not bound to proteins in the blood.[10] The link showed up in healthy men who drink regularly, not after a single drinking session and not in groups with diagnosed alcohol use disorder.[10] So the habit counts, not the occasional party, although no study in the analysis tested whether testosterone recovers after quitting.[10] If you drink a lot every day, do not stop abruptly on your own.[29] Withdrawal can start within hours and can become dangerous, so get medical advice first.[29]
Exercise is where gym folklore runs furthest ahead of the data. In men aged 60 and over, resistance training did not change resting testosterone, while endurance and interval training raised it slightly.[3] Younger men were not studied in this analysis. A hard session can cause a short-lived rise that does not change your resting level, so lift for strength and fitness rather than as a testosterone pill.
Sleep apnea is a similar case of a treatment worth doing for reasons other than testosterone. CPAP, the breathing mask for nighttime breathing pauses, did not change testosterone on average in a small meta-analysis, and larger trials are still missing.[4] It does not help you lose weight either; if anything, weight tends to rise slightly on it.[30] If you have sleep apnea, keep using CPAP for its own sake and work on weight separately.
How much these levers can do depends on where you start. For a lean man who sleeps enough and drinks little, our reading of these studies is that not much natural room is left. If symptoms persist in that case, a blood test is the best next step, because it shows whether there is a real deficiency to treat.
Foods, zinc, vitamin D and boosters: Do they raise testosterone?
No single food meaningfully raises a normal man's testosterone. Among supplements, zinc is the one with a clear use: it may help if you lack it, while the evidence for a gain without a deficiency is weak.[5] Oysters and eggs have a better reputation than evidence, vitamin D showed no clear effect in most trials, and over-the-counter boosters are unproven.[11][26][32] What you eat and drink still matters in two less obvious ways. In men with obesity, a diet that took off excess weight raised testosterone.[27] Regular drinking is linked to lower levels, so cutting back is another reasonable step.[10]
Zinc has a real case where it applies, in men who lack it. A systematic review found that low zinc goes with low testosterone and that supplements raised testosterone, though the effect depended on starting levels, dose and duration.[5] Most of its studies were in animals (30 of 38), so the human evidence is thin.[5] Our reading: zinc is worth taking when it corrects a deficiency, which is where its benefit sits, rather than as a general booster. Do not take more than 25 mg of zinc a day from all sources without medical advice, because long-term excess can cause copper deficiency.[31]
Vitamin D has been tested more carefully than zinc, and the results lean toward no effect. Most trials found no clear testosterone benefit, including a well-run randomized trial in healthy men.[6][7][32] The most recent pooled analysis reached the same conclusion, although it rated the certainty of its evidence as low.[32] One other pooled analysis did find a small overall rise.[8] In exploratory subgroups, that rise stood out at doses above 4,000 IU a day and with use beyond 12 weeks.[8] Those subgroups do not set a dose that works, and they are not dosing advice. The official upper limit for adults is 4,000 IU (100 micrograms) a day, and higher doses belong under medical supervision.[33]
A vitamin D deficiency itself is not rare in Germany. In national survey data from 2008 to 2011, about 15 percent of adults had a vitamin D level below 30 nmol/L, the usual cutoff for deficiency.[34] That figure comes from lab values that were standardized afterwards, and levels are lowest in late winter.[9] If a blood test shows a deficiency, correcting it with your doctor is worthwhile in its own right; just do not count on a testosterone gain from it.[32]
Testosterone boosters sold over the counter have even less behind them than vitamin D. D-aspartic acid at 6 grams a day did not change resting total or free testosterone in resistance-trained men over three months.[11] In an earlier two-week trial, the same dose even lowered both.[25] Tribulus showed no reliable testosterone effect in a systematic review, and its only two small rises were in men with a diagnosed deficiency.[26] Your money and effort go further on weight, sleep and alcohol than on these boosters.
Low testosterone: Symptoms, normal levels and how to test
The symptoms that point most clearly to low testosterone are sexual: fewer morning erections, low sex drive and erectile dysfunction. In the EMAS study of European men aged 40 to 79, exactly these three tracked low testosterone best.[13] Tiredness, low mood, poor concentration, less muscle and more body fat also show up, but they have many other causes.[12] So symptoms raise the question, and only a blood test can answer it.
Once you have symptoms, the first test is a fasting morning total testosterone, which counts all the testosterone in the blood.[12] Testosterone varies over the day and is highest in the morning, which is why a single random value is no good for a diagnosis.[12] Testing men without symptoms is not recommended.[12]
A low first result is repeated with a second fasting morning test, because a diagnosis of hypogonadism, a genuine testosterone deficiency, needs symptoms and consistently low values.[12] That double rule is the main guard against a wrong diagnosis and against starting treatment too early.
Where "low" begins depends on who draws the line. The Endocrine Society's reference range for healthy non-obese men aged 19 to 39 runs from 264 to 916 ng/dL (9.2 to 31.8 nmol/L).[12] So 264 ng/dL marks the lower end of normal in young men. Other bodies draw the line slightly higher. The American Urological Association (AUA) uses 300 ng/dL (10.4 nmol/L),[16] and the EMAS study used 11 nmol/L in its strict research definition.[13] Values between about 9 and 11 nmol/L are a grey zone.[12] There, symptoms, a repeat test, your lab's own range and free testosterone, the share not bound to proteins in the blood, decide.[12] The table puts these thresholds side by side in the three units labs use:
Sources: Endocrine Society[12] AUA,[16] TRAVERSE,[20] EMAS.[13] To convert, multiply ng/mL by 3.47 to get nmol/L. The guideline sets no separate cutoff per age, and older men simply fall below it more often.[12][13]
The EMAS cutoff belongs to a strict research definition of late-onset hypogonadism, the form that comes with age. All three conditions had to apply: total testosterone below 11 nmol/L, free testosterone below 220 pmol/L and the three sexual symptoms.[13] That definition was built to count cases in a population, which is why it is stricter than what a doctor needs to decide about one patient.
For that one patient, two more markers help when the total value is borderline. The first is SHBG (sex hormone-binding globulin), the transport protein that binds testosterone in the blood.[12] Obesity and diabetes lower it, while aging, an overactive thyroid, liver cirrhosis and hepatitis raise it.[12] If SHBG is off or total testosterone is borderline, the second marker is free testosterone.[12] The reference method is equilibrium dialysis, in which the lab separates the free hormone from the bound part.[12] A validated calculation also works.[12] A direct analog immunoassay is a cheaper test, but it is unreliable for free testosterone.[12]
LH and FSH, the control hormones from the pituitary gland, then show where the problem sits. High LH and FSH alongside low testosterone point to the testes themselves. Low or normal LH and FSH point instead to the brain's control centres, the pituitary or hypothalamus, which is the typical pattern in obesity and metabolic disorders.[12][27]
Home tests exist, usually as a finger-prick blood kit that you mail to a lab. The reading itself may be fine, but a single home test cannot replace the sequence a diagnosis needs.[12] That sequence runs from symptoms to two fasting morning measurements and, if needed, free testosterone, SHBG, LH and FSH.[12] A home result can be a reason to see a doctor, but it is not a diagnosis.
In Germany, symptoms are also what opens the door to an insurance-paid test. Statutory insurance (GKV) covers care that is needed to detect an illness.[44] With symptoms, your GP or urologist can therefore order testosterone as part of a workup. A pure curiosity check without symptoms is usually self-pay or IGeL (an individual health service).
Erection problems: Low testosterone or an early heart warning?
New erection problems are often an early warning of heart and blood-vessel disease, sometimes years before the heart itself causes symptoms.[14][15] The likely reason is vessel size, since the same damage to the inner vessel wall cuts blood flow in the small penile arteries sooner than in the larger coronary ones.[35] That makes erectile dysfunction the canary in the coal mine for the vessels.
The timing shows up in men who already have heart disease. Among men with stable coronary disease and erection problems, the erection problems came first in 93 percent, on average about two years earlier.[14] Studies that follow men forward over time point the same way. In a meta-analysis of such studies, men with erectile dysfunction had about 50 percent more cardiovascular events and a somewhat higher overall death rate.[15] That link was probably independent of the classic risk factors.[15] Because these studies observe rather than test, they show erectile dysfunction as a marker that goes with heart risk, not as its cause.
A marker is still useful, because erection problems and heart disease share the same risk factors. Diabetes, smoking, high blood pressure, high blood lipids, excess weight and inactivity all damage the inner vessel wall.[35] That is why new erection problems are a reason to check blood pressure, glucose and lipids, the same basics the men 40-plus hub covers for your 40s.[16][35] Men at high cardiovascular risk should also get a heart check-up.[16][35]
Testosterone, for all the attention it gets, is not the standard treatment for erectile dysfunction. Sildenafil belongs to a group of erection medicines called PDE5 inhibitors and is a common first treatment.[16] The American Urological Association accepts any suitable option as a first treatment, chosen together with your doctor.[16] On its own, testosterone is not an effective treatment for erectile dysfunction. In men with a proven deficiency, though, combining it with a PDE5 inhibitor can work better than the PDE5 inhibitor alone.[16]
Two practical points come with PDE5 inhibitors. Never combine one with nitrates, such as nitroglycerin spray for angina, because together they can make blood pressure drop dangerously.[16] Statutory insurance also does not pay for erection drugs, since they are excluded as lifestyle drugs.[36] If tests later prove a testosterone deficiency and treatment is considered, the prostate is checked before it starts.[18]
PSA screening: Is it worth it, and does TRT cause prostate cancer?
A PSA test can lower the risk of dying from prostate cancer a little, but it also finds many cancers that would never have caused harm.[22][23] That makes it a trade-off rather than a free check. PSA (prostate-specific antigen) is a protein from the prostate that is measured in the blood. A raised value can come from cancer but also from benign enlargement or inflammation, which is why it triggers further tests rather than making a diagnosis.[18]
The European ERSPC trial shows both sides of that trade-off. After 23 years, PSA screening cut prostate-cancer deaths by 13 percent.[22] To prevent one of those deaths, 456 men had to be invited and 12 extra cancers diagnosed.[22] Nine years in, it had taken about 1,410 invitations and 48 extra diagnoses,[17] so the balance improves with longer follow-up. Even so, each prevented death still costs many biopsies, diagnoses and treatments, which carry a risk of incontinence and impotence.
Those extra diagnoses are the core of the overdiagnosis problem. A modelling study used ERSPC data to estimate how many cancers found by PSA-only screening at age 55 to 67 were overdiagnosed.[23] Its answer was about half, meaning those cancers would never have caused problems in the man's lifetime.[23] Newer risk-adapted pathways with MRI are designed to lower this, which is also what the 23-year ERSPC report calls for.[22]
Germany's guideline has moved toward that risk-adapted approach, while statutory insurance has not followed yet. Under the German S3 guideline on prostate cancer (2025), men from 45 who want early detection and expect to live at least ten more years should get open-ended counselling.[18] Men who still want screening afterwards should be offered a PSA test, and the PSA value then sets the follow-up.[18] The guideline advises against the finger exam for early detection.[18] Yet statutory insurance still pays only for an annual prostate palpation from 45, while PSA screening remains self-pay (IGeL).[37] The G-BA, the body that decides what statutory insurance covers, is now reviewing the risk-adapted approach.[37] Its review of screening with PSA and MRI for men aged 50 to 70 opened in October 2025, with a result due by October 2027 at the latest.[37] As of October 2026 the assessment is still running, so nothing has changed for patients yet.[37]
Does testosterone therapy cause prostate cancer?
In carefully screened men, the largest trial found no clear difference in new prostate cancers, but there were too few cases to rule out an increase.[19] The TRAVERSE prostate substudy followed 5,204 men with diagnosed low testosterone.[19] High-grade prostate cancer was rare in both groups, and neither it nor cancers of any grade or other prostate events differed clearly between testosterone and placebo.[19] The screening was strict, because the trial excluded men with a PSA above 3 ng/mL.[19] Treatment also lasted under two years on average, and PSA rose more on testosterone.[19]
That result is reassuring for men without prostate cancer who are screened first. It says nothing about men who already have prostate cancer, since known or suspected prostate cancer rules testosterone out.[38] For everyone else who considers testosterone therapy, the German guideline requires a PSA test and a prostate exam before starting.[18] Once treatment runs, prostate cancer risk is assessed again during the first year.[12]
TRT in Germany: Who qualifies, who should not, and what it costs
TRT (testosterone replacement therapy) is a treatment for a diagnosed testosterone deficiency, and with that diagnosis statutory insurance pays for it apart from a small co-pay.[21][38] Without a diagnosis you pay the full price yourself.[41][42] So whether a genuine hypogonadism is documented decides which of the two applies.
A genuine deficiency is less common than the marketing suggests. About 2 percent of men aged 40 to 79 met the strict EMAS definition of late-onset hypogonadism.[13] The share rose with age, from 0.1 percent at 40 to 49 to 5.1 percent at 70 to 79.[13] A looser definition would count more men, but the point stands: most men with low energy do not have a testosterone deficiency that needs treatment.
Who should not start testosterone
Testosterone is prescription-only in Germany,[38] and even a confirmed deficiency does not make it right for everyone. Guidelines advise against starting it if you want to father a child soon, because testosterone suppresses sperm production.[12][38] In that case a specialist should look at alternatives.[12][38] Testosterone is also ruled out, or needs a specialist work-up first, with any of the following.[12]:
- prostate or breast cancer
- a suspicious prostate finding or raised PSA
- a high hematocrit (the share of red blood cells in the blood)
- untreated severe sleep apnea
- severe urinary symptoms
- uncontrolled heart failure
- a heart attack or stroke in the last six months
- a clotting disorder
For men who do start, testosterone level, hematocrit and prostate are checked, especially in the first year[12] Blood pressure is checked too, because testosterone can raise it.[38][39] Since 2025 the FDA, the US drug regulator, has required a warning about this on all testosterone products.[38][39] Gel can also transfer to partners and children through skin contact. With Testogel, wash your hands after applying it and cover the dried site with clothing.[38] Before close contact, wait at least one hour after applying, then wash the site with soap and water and cover it again.[38] Other gels follow their own label.[38]
What TRAVERSE showed about safety
The largest safety trial so far is TRAVERSE. It enrolled about 5,200 men with diagnosed low testosterone (below 300 ng/dL on two fasting tests) and high cardiovascular risk.[20] Testosterone gel did no worse than placebo for major heart events, but some other problems were more common on testosterone, as the table shows.[20]:
| Event | Testosterone (%) | Placebo (%) |
|---|---|---|
| Major heart events | 7.0 | 7.3 |
| Atrial fibrillation (irregular heartbeat) | 3.5 | 2.4 |
| Pulmonary embolism (clot in the lung) | 0.9 | 0.5 |
| Acute kidney injury | 2.3 | 1.5 |
| Fractures (substudy) | 3.5 | 2.5 |
Source: TRAVERSE[20] and its fracture substudy[24] Because TRAVERSE tested a gel and left injections out,[20] its results describe monitored gel treatment, not every form of testosterone.
What statutory insurance pays
Testosterone is approved for male hypogonadism confirmed by symptoms and two separate blood tests.[38] In that case statutory insurance pays for it like any other prescription drug, and you pay the standard co-pay per prescription item.[21] That co-pay is 10 percent of the price, at least 5 and at most 10 euros, but never more than the drug costs (as of October 2026).[21] From 1 January 2027 the limits rise to 7.50 and 15 euros.[40] Prescribing testosterone at the insurer's expense for anti-aging or lifestyle reasons is not allowed, because services must be necessary and economical.[43] An uneconomical prescription can lead to a claw-back from the doctor, known as a Regress.[43]
What self-payers pay
Without a diagnosis, raising a normal man's testosterone falls outside the approved use (off-label) and is self-pay.[38] The table shows what two preparations cost at the pharmacy:
These are pharmacy prices for the drug alone at the standard dose, as of October 2026[41][42] Higher doses cost more, and self-payers also pay for doctor visits and lab tests on top. Before starting, we would ask for the full cost of drug, appointments and lab tests, including what insurance covers.
Frequently asked questions
Can I really raise my testosterone naturally?
Does resistance training raise my testosterone permanently?
Which foods raise testosterone?
Does a zinc or vitamin D supplement do anything for my testosterone?
How do I test my testosterone correctly?
Is erectile dysfunction an early warning sign for the heart?
Does testosterone replacement therapy cause prostate cancer?
What does TRT cost in Germany?
What is a normal testosterone level for men (nmol/L, ng/dL, ng/mL)?
What are the symptoms of low testosterone?
Do testosterone boosters from the drugstore or pharmacy work?
How fast can you raise testosterone naturally?
Can I take testosterone if I want children?
What should be checked while I am on TRT?
Can I take sildenafil if I have heart disease?
Sources44
- Leproult R, Van Cauter E. (2011). Effect of 1 Week of Sleep Restriction on Testosterone Levels in Young Healthy Men. JAMAdoi:10.1001/jama.2011.710
- Nayak SS, Partheepan K, Mantena S, et al. (2026). The Effect of Weight Loss and Weight Loss Interventions on Sex Hormones: An Umbrella Review of Systematic Reviews and Meta-Analyses. Endocrine Practicedoi:10.1016/j.eprac.2025.10.014
- Hayes LD, Elliott BT. (2019). Short-Term Exercise Training Inconsistently Influences Basal Testosterone in Older Men: A Systematic Review and Meta-Analysis. Frontiers in Physiologydoi:10.3389/fphys.2018.01878
- Zhang XB, Jiang XT, Du YP, Yuan YT, Chen B. (2014). Efficacy of Continuous Positive Airway Pressure on Testosterone in Men with Obstructive Sleep Apnea: A Meta-Analysis. PLOS ONEdoi:10.1371/journal.pone.0115033
- Te L, Liu J, Ma J, Wang S. (2023). Correlation between serum zinc and testosterone: A systematic review. Journal of Trace Elements in Medicine and Biologydoi:10.1016/j.jtemb.2022.127124
- Lerchbaum E, Pilz S, Trummer C, Schwetz V, Pachernegg O, Heijboer AC, Obermayer-Pietsch B. (2017). Vitamin D and Testosterone in Healthy Men: A Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolismdoi:10.1210/jc.2017-01428
- Hosseini Marnani E, et al. (2019). The effect of vitamin D supplementation on the androgenic profile in men: A systematic review and meta-analysis of clinical trials. Andrologiadoi:10.1111/and.13343
- Abu-Zaid A, et al. (2024). The Impact of Vitamin D on Androgens and Anabolic Steroids among Adult Males: A Meta-Analytic Review. Diseasesdoi:10.3390/diseases12100228
- Rabenberg M, Scheidt-Nave C, Busch MA, Rieckmann N, Hintzpeter B, Mensink GBM. (2015). Vitamin D status among adults in Germany: results from the German Health Interview and Examination Survey for Adults (DEGS1). BMC Public Healthdoi:10.1186/s12889-015-2016-7
- Santi D, et al. (2024). The chronic alcohol consumption influences the gonadal axis in men: Results from a meta-analysis. Andrologydoi:10.1111/andr.13526
- Melville GW, Siegler JC, Marshall PWM. (2017). The effects of d-aspartic acid supplementation in resistance-trained men over a three month training period: A randomised controlled trial. PLOS ONEdoi:10.1371/journal.pone.0182630
- Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolismdoi:10.1210/jc.2018-00229
- Wu FCW, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva FF, Forti G, et al. (2010). Identification of late-onset hypogonadism in middle-aged and elderly men. New England Journal of Medicinedoi:10.1056/NEJMoa0911101
- Montorsi P, Ravagnani PM, Galli S, Rotatori F, Veglia F, Briganti A, Salonia A, Deho F, Rigatti P, Montorsi F, Fiorentini C. (2006). Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. European Heart Journaldoi:10.1093/eurheartj/ehl142
- Dong JY, Zhang YH, Qin LQ. (2011). Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. Journal of the American College of Cardiologydoi:10.1016/j.jacc.2011.06.024
- Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, et al. (2018). Erectile Dysfunction: AUA Guideline. The Journal of Urologydoi:10.1016/j.juro.2018.05.004
- Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, et al. (2009). Screening and prostate-cancer mortality in a randomized European study. New England Journal of Medicinedoi:10.1056/NEJMoa0810084
- Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). (2025). S3-Leitlinie Prostatakarzinom, Langversion 8.1. Leitlinienprogramm Onkologie, AWMF-Registernummer 043-022OLleitlinienprogramm-onkologie.de
- Bhasin S, Travison TG, Pencina KM, O'Leary M, Cunningham GR, Lincoff AM, Nissen SE, et al. (2023). Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Network Opendoi:10.1001/jamanetworkopen.2023.48692
- Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM, et al. (2023). Cardiovascular Safety of Testosterone-Replacement Therapy. New England Journal of Medicinedoi:10.1056/NEJMoa2215025
- Bundesministerium der Justiz. (2026). Sozialgesetzbuch (SGB) Fünftes Buch, § 61 Zuzahlungen. gesetze-im-internet.degesetze-im-internet.de
- Roobol MJ, de Vos II, Månsson M, Godtman RA, Talala KM, et al.; ERSPC Investigators. (2025). European Study of Prostate Cancer Screening: 23-Year Follow-up. New England Journal of Medicinedoi:10.1056/NEJMoa2503223
- Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Schröder FH, de Koning HJ. (2003). Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer. Journal of the National Cancer Institutedoi:10.1093/jnci/95.12.868
- Snyder PJ, Bauer DC, Ellenberg SS, Cauley JA, Buhr KA, Bhasin S, Miller MG, Khan NS, Li X, Nissen SE. (2024). Testosterone Treatment and Fractures in Men with Hypogonadism. New England Journal of Medicinedoi:10.1056/NEJMoa2308836
- Melville GW, Siegler JC, Marshall PWM. (2015). Three and six grams supplementation of d-aspartic acid in resistance trained men. Journal of the International Society of Sports Nutritiondoi:10.1186/s12970-015-0078-7
- Vilar Neto JO, de Moraes WMAM, Pinto DV, et al. (2025). Effects of Tribulus (Tribulus terrestris L.) Supplementation on Erectile Dysfunction and Testosterone Levels in Men: A Systematic Review of Clinical Trials. Nutrientsdoi:10.3390/nu17071275
- Corona G, Rastrelli G, Monami M, Saad F, Luconi M, Lucchese M, Facchiano E, Sforza A, Forti G, Mannucci E, Maggi M. (2013). Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. European Journal of Endocrinologydoi:10.1530/EJE-12-0955
- Su L, Zhang SZ, Zhu J, Wu J, Jiao YZ. (2021). Effect of partial and total sleep deprivation on serum testosterone in healthy males: a systematic review and meta-analysis. Sleep Medicinedoi:10.1016/j.sleep.2021.10.031
- Mirijello A, D'Angelo C, Ferrulli A, Vassallo G, Antonelli M, Caputo F, Leggio L, Gasbarrini A, Addolorato G. (2015). Identification and management of alcohol withdrawal syndrome. Drugsdoi:10.1007/s40265-015-0358-1
- Drager LF, Brunoni AR, Jenner R, Lorenzi-Filho G, Benseñor IM, Lotufo PA. (2015). Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials. Thoraxdoi:10.1136/thoraxjnl-2014-205361
- Schoofs H, Schmit J, Rink L. (2024). Zinc Toxicity: Understanding the Limits. Moleculesdoi:10.3390/molecules29133130
- Paez-Allendes L, Valenzuela-Fuenzalida JJ, Moya MP, Oyanedel G, et al. (2026). Vitamin D Supplementation, Total Testosterone, and Androgen Bioavailability Markers in Adult Men: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrientsdoi:10.3390/nu18132090
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA); Turck D, Bohn T, Castenmiller J, et al. (2023). Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate. EFSA Journaldoi:10.2903/j.efsa.2023.8145
- Rabenberg M, Scheidt-Nave C, Busch MA, Thamm M, Rieckmann N, Durazo-Arvizu RA, Dowling KG, Škrabáková Z, Cashman KD, Sempos CT, Mensink GBM. (2018). Implications of standardization of serum 25-hydroxyvitamin D data for the evaluation of vitamin D status in Germany, including a temporal analysis. BMC Public Healthdoi:10.1186/s12889-018-5769-y
- Gandaglia G, Briganti A, Jackson G, Kloner RA, Montorsi F, Montorsi P, Vlachopoulos C. (2014). A systematic review of the association between erectile dysfunction and cardiovascular disease. European Urologydoi:10.1016/j.eururo.2013.08.023
- Bundesministerium der Justiz. (2026). Sozialgesetzbuch (SGB) Fünftes Buch, § 34 Ausgeschlossene Arznei-, Heil- und Hilfsmittel. gesetze-im-internet.degesetze-im-internet.de
- Gemeinsamer Bundesausschuss (G-BA). (2025). Einleitung des Beratungsverfahrens: Bewertung eines risikoadaptierten PSA- und MRT-Screenings zur Früherkennung eines Prostatakarzinoms (Beschluss vom 16.10.2025) und Pressemitteilung 'Früherkennung von Prostatakrebs: G-BA prüft risikoabhängiges Angebot'. g-ba.deg-ba.de
- Besins Healthcare Germany GmbH. (2024). Fachinformation Testogel Dosiergel 16,2 mg/g Gel. Fachinformation (Stand November 2024)fachinfo.de
- U.S. Food and Drug Administration. (2025). FDA issues class-wide labeling changes for testosterone products. FDA Drug Alerts and Statements (28 Feb 2025)fda.gov
- Bundesgesetzblatt. (2026). Gesetz zur Stabilisierung der Beitragssätze in der gesetzlichen Krankenversicherung (GKV-Beitragssatzstabilisierungsgesetz) vom 24. Juli 2026, Art. 1 Nr. 23 (§ 61 SGB V, in Kraft ab 1. Januar 2027). BGBl. 2026 I Nr. 228recht.bund.de
- aponeo Versandapotheke. (2026). Testogel: Packungen und Apothekenpreise (Stand Oktober 2026). aponeo.deaponeo.de
- aponeo Versandapotheke. (2026). Nebido 1000 mg Injektionslösung Durchstechflasche, PZN 07052371: Apothekenpreis (Stand Oktober 2026). aponeo.deaponeo.de
- Bundesministerium der Justiz. (2026). Sozialgesetzbuch (SGB) Fünftes Buch, § 106b Wirtschaftlichkeitsprüfung ärztlich verordneter Leistungen. gesetze-im-internet.degesetze-im-internet.de
- Bundesministerium der Justiz. (2026). Sozialgesetzbuch (SGB) Fünftes Buch, § 27 Krankenbehandlung. gesetze-im-internet.degesetze-im-internet.de
Men's health without the bro-science
At Longevity China, men talk through lab values, TRT questions and what actually works, evidence-based and with no supplement sales.
Join the communityExperts in this field
Speakers from the Longevity China community on this topic
Related guides
- Self-pay longevity in GermanyWhich longevity services German statutory insurance covers, which you self-pay, typical prices, and whether private insurance is worth it
- Longevity for men 40+Hormones, heart markers, strength, and mental health in midlife. Testosterone, ApoB, sarcopenia, and the honest truth about alcohol and sleep.
- ApoB and Lp(a): The cardio markers your doctor might not orderWhy ApoB now beats LDL-C, why Lp(a) is a genetic risk marker you inherit, and how to actually get tested in DE, AT, and CH.
- HRT & TRT: Protocols and honest evidenceWhat the WHI re-analysis actually flipped. What the T-Trials and TRAVERSE 2023 showed. And how HRT and TRT are really prescribed in DACH.
Created by Maurice Lichtenberg, Founder, Longevity Cities
The information provided here is for educational purposes only. Longevity China does not provide medical advice, diagnosis, or treatment. Always seek the advice of qualified healthcare providers with questions regarding medical conditions.
